Products for Research Use Only

HDAC6-IN-22

CAT: 0804-HY-156279Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-156279Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HDAC6-IN-22 (compound 30) is a inhibitor of HDAC6, with the IC50 of 4.63 nM. HDAC6-IN-22 has antiproliferative effects in vitro and in vivo towards multiple myeloma. HDAC6-IN-22 induces cell cycle arrest in the G2 phase and promotes apoptosis through the mitochondrial pathway[1].
UNSPSC
12352005
Target
Apoptosis; HDAC
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac6-in-22.html
Solubility
10 mM in DMSO
Smiles
CN1C2=CC=C(C(NO)=O)C=C2N=C1[C@H](CC3=CC=CC=C3)NCC4=CC=CC=C4
Molecular Formula
C24H24N4O2
Molecular Weight
400.47
References & Citations
[1]Liu L, et al. Design and synthesis of 1H-benzo[d]imidazole selective HDAC6 inhibitors with potential therapy for multiple myeloma [published online ahead of print, 2023 Sep 25]. Eur J Med Chem. 2023;261:115833.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Popular Products